Literature DB >> 7956597

Fecal lactate and short bowel syndrome.

D Bustos1, S Pons, J C Pernas, H Gonzalez, M I Caldarini, K Ogawa, J A De Paula.   

Abstract

In patients with short bowel syndrome (SBS), the carbohydrate overload to the colon may disturb the normal pattern of colonic fermentation with production of D-lactic acid and subsequent development of a metabolic D-lactic acidosis. We measured D-lactic acid in blood, urine, and feces, as well as the composition of fecal water and fecal reducing substances from 11 patients with SBS, comparing the results with those from normal subjects. The fecal water from patients with SBS was characterized by low pH, potassium, and volatile fatty acids, high osmotic gap, and high concentration of L- and D-lactic acid. Five of 11 had abnormal amounts of fecal reducing substances. Fecal D-lactic acid was increased in nine of 11 patients. However, none of these patients showed D-lactic acid in urine, and only one had a very low concentration in plasma. These results show that D-lactic acid was overproduced in the colon of most of the patients with SBS. However, other factors such as absorption or impaired D-lactic acid metabolism may be necessary for a plasmatic increase of D-lactic acid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956597     DOI: 10.1007/BF02087644

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  The contribution of the colon to electrolyte and water conservation in man.

Authors:  S F Phillips; J Giller
Journal:  J Lab Clin Med       Date:  1973-05

2.  The metabolism of D-alpha-hydroxy acids in animal tissues.

Authors:  P K Tubbs
Journal:  Ann N Y Acad Sci       Date:  1965-07-31       Impact factor: 5.691

3.  Quantitation of fecal carbohydrate excretion in patients with short bowel syndrome.

Authors:  V Z Ameen; G K Powell; L A Jones
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

4.  Metabolic utilization and renal handling of D-lactate in men.

Authors:  M S Oh; J Uribarri; D Alveranga; I Lazar; N Bazilinski; H J Carroll
Journal:  Metabolism       Date:  1985-07       Impact factor: 8.694

Review 5.  Volatile fatty acids: their production, absorption, utilization, and roles in human health.

Authors:  S E Fleming; D S Arce
Journal:  Clin Gastroenterol       Date:  1986-10

6.  Effect of lactate and H+ on structure and function of rat intestine.

Authors:  D R Saunders; J Sillery
Journal:  Dig Dis Sci       Date:  1982-01       Impact factor: 3.199

7.  D-Lactic acidosis in children: an unusual metabolic complication of small bowel resection.

Authors:  D H Perlmutter; J T Boyle; J M Campos; J M Egler; J B Watkins
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

8.  Absorption of short-chain fatty acids by the colon.

Authors:  H Ruppin; S Bar-Meir; K H Soergel; C M Wood; M G Schmitt
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

9.  Short-chain fatty acids induce reversible injury of porcine colon.

Authors:  R A Argenzio; D J Meuten
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

10.  D-lactic acidosis in two patients with short bowel syndrome: bacteriological analyses of the fecal flora.

Authors:  T Satoh; K Narisawa; T Konno; T Katoh; J Fujiyama; A Tomoe; K Metoki; K Hayasaka; K Tada; M Ishibashi; N Yamane; T Mitsuoka; Y Benno
Journal:  Eur J Pediatr       Date:  1982-07       Impact factor: 3.183

View more
  14 in total

1.  Different ionic conditions prompt NHE2 and NHE3 translocation to the plasma membrane.

Authors:  J Scott Gens; Hongwei Du; Lixuan Tackett; Shen-Shen Kong; Shaoyou Chu; Marshall H Montrose
Journal:  Biochim Biophys Acta       Date:  2007-01-12

Review 2.  Lactulose, disaccharides and colonic flora. Clinical consequences.

Authors:  M R Clausen; P B Mortensen
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

3.  Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production.

Authors:  M I Caldarini; S Pons; D D'Agostino; J A DePaula; G Greco; G Negri; A Ascione; D Bustos
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

4.  Effect of L-lactic acid, short-chain fatty acids, and pH in cecal infusate on morphometric and cell kinetic parameters of rat cecum.

Authors:  H Ichikawa; T Sakata
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

5.  Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production.

Authors:  T Jiang; D A Savaiano
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

6.  Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli.

Authors:  T Kaneko; Y Bando; H Kurihara; K Satomi; K Nonoyama; N Matsuura
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate.

Authors:  M R Clausen; J Jørgensen; P B Mortensen
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

8.  A stand-alone synbiotic treatment for the prevention of D-lactic acidosis in short bowel syndrome.

Authors:  Kazuhiro Takahashi; Hideo Terashima; Keisuke Kohno; Nobuhiro Ohkohchi
Journal:  Int Surg       Date:  2013 Apr-Jun

9.  Behavior of lactobacilli isolated from fermented slurry (ben-saalga) in gnotobiotic rats.

Authors:  Williams Turpin; Christèle Humblot; Marie-Louise Noordine; Laura Wrzosek; Julie Tomas; Camille Mayeur; Claire Cherbuy; Jean-Pierre Guyot; Muriel Thomas
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome.

Authors:  Camille Mayeur; Jean-Jacques Gratadoux; Chantal Bridonneau; Fatima Chegdani; Béatrice Larroque; Nathalie Kapel; Olivier Corcos; Muriel Thomas; Francisca Joly
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.